This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


HanAll Biopharma Co., Ltd.

Drug Names(s): HL143, HL-143, Engineered interferon alpha-2b

Description: HL143 is a single amino acid variant of native IFN-alpha-2a that utilizes Resistein technology to engineer a protease resistant variant that has longer half-life compared to native IFN-alpha.

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug